Search

Your search keyword '"Hyper-CVAD"' showing total 1 results
Start Over Descriptor "Hyper-CVAD" Region united states
1 results on '"Hyper-CVAD"'

1. Phase 2 Trial of Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus Methotrexate- Cytarabine for Relapsed or Refractory Aggressive Mantle Cell Lymphoma.

Author

Wang, Michael, Fayad, Luis, Cabanillas, Fernando, Hagemeister, Fredrick, McLaughlin, Peter, Rodriguez, Maria A., Kwak, Larry W., Yuhong Zhou, Kantarjian, Hagop, and Romaguera, Jorge

Subjects
*ANTINEOPLASTIC agents, *LYMPHOMA treatment, *DRUG side effects, *IMMUNOSUPPRESSIVE agents
Abstract

The article presents the clinical trial of several antineoplastic agents including rituximab, methotrexate, and cytarabine which treat patients with refractory mantle cell lymphoma (MCL) in the U.S. It notes that toxicity, neutropenic fever, and thrombocytopenia are the side effects of the anticancer agents. Moreover, it emphasizes the effectiveness of chemotherapeutic agents including cyclophosphamide, vincristine, and doxorubicin on treating MCL.

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results